Icotrokinra yields high clearance and durable response rates at high-impact sites in patients with psoriasis, with no added adverse events compared with placebo, a 1-year assessment of a trial shows.
Medscape News UK
Source link : https://www.medscape.com/viewarticle/can-oral-icotrokinra-provide-long-term-relief-high-impact-2026a1000iby?src=rss
Author :
Publish date : 2026-06-04 12:00:00
Copyright for syndicated content belongs to the linked Source.
